![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
![[Contents]](/icons/banner/tocACT.gif){kind=icon}
|
|
|
|
|
||
M Santostefano, M Merchant, L Arellano, V Morrison, MS Denison and S Safe
Department of Veterinary Physiology and Pharmacology, Texas A & M University, College Station 77843-4466.
alpha-Naphthoflavone (alpha NF) is a weak aryl hydrocarbon (Ah) receptor agonist and inhibits the induction of CYP1A1 gene expression by 2,3,7,8-tetrachlorodibenzo-p-dioxin. It has been suggested that the Ah receptor antagonist activity is due to the formation of alpha NF- cytosolic Ah receptor complexes that fail to undergo transformation. This hypothesis is consistent with data obtained in this and other studies using alpha NF concentrations from 10 to 1000 nM. However, 10 microM alpha NF exhibited Ah receptor agonist activity in several assays. Incubation of rat hepatic cytosol with 10 microM alpha NF caused transformation of the Ah receptor, as determined in a gel retardation assay using a 32P-labeled oligonucleotide containing a single dioxin-responsive element (DRE). Incubation of rat hepatoma (H-4- II E) cells with 10 microM alpha NF not only resulted in the induction of CYP1A1 mRNA levels but also increased chloramphenicol acetyltransferase activity from a DRE-containing chloramphenicol acetyltransferase reporter plasmid. Moreover, the DRE-transformed cytosolic Ah receptor complex liganded with either alpha NF or 2,3,7,8- tetrachlorodibenzo-p-dioxin did not undergo significant dissociation at 4 degrees. These data confirm that alpha NF is an Ah receptor agonist and, based on the results of previous studies, exhibits partial antagonist activity via competition for receptor binding sites.
This article has been cited by other articles:
|
|
 |
|
  M. Chang, K.-w. Peng, I. Kastrati, C. R. Overk, Z.-H. Qin, P. Yao, J. L. Bolton, and G. R. J. Thatcher Activation of Estrogen Receptor-Mediated Gene Transcription by the Equine Estrogen Metabolite, 4-Methoxyequilenin, in Human Breast Cancer Cells Endocrinology, October 1, 2007; 148(10): 4793 - 4802. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Du, M. M. Neis, P. A. Ladd, and D. S. Keeney Differentiation-Specific Factors Modulate Epidermal CYP1-4 Gene Expression in Human Skin in Response to Retinoic Acid and Classic Aryl Hydrocarbon Receptor Ligands J. Pharmacol. Exp. Ther., December 1, 2006; 319(3): 1162 - 1171. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Aluru, R. Renaud, J. F. Leatherland, and M. M. Vijayan Ah Receptor-Mediated Impairment of Interrenal Steroidogenesis Involves StAR Protein and P450scc Gene Attenuation in Rainbow Trout Toxicol. Sci., April 1, 2005; 84(2): 260 - 269. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J.-g. Zhou, E. C. Henry, C. M. Palermo, S. D. Dertinger, and T. A. Gasiewicz Species-Specific Transcriptional Activity of Synthetic Flavonoids in Guinea Pig and Mouse Cells as a Result of Differential Activation of the Aryl Hydrocarbon Receptor to Interact with Dioxin-Responsive Elements Mol. Pharmacol., April 1, 2003; 63(4): 915 - 924. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. J. Gambone, J. M. Hutcheson, J. L. Gabriel, R. L. Beard, R. A.S. Chandraratna, K. J. Soprano, and D. R. Soprano Unique Property of Some Synthetic Retinoids: Activation of the Aryl Hydrocarbon Receptor Pathway Mol. Pharmacol., February 1, 2002; 61(2): 334 - 342. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. A. Nazarenko, S. D. Dertinger, and T. A. Gasiewicz In Vivo Antagonism of AhR-Mediated Gene Induction by 3'-Methoxy-4'-nitroflavone in TCDD-Responsive lacZ Mice Toxicol. Sci., June 1, 2001; 61(2): 256 - 264. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J.-E. Lee and S. Safe 3',4'-Dimethoxyflavone as an Aryl Hydrocarbon Receptor Antagonist in Human Breast Cancer Cells Toxicol. Sci., December 1, 2000; 58(2): 235 - 242. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. D. Seidel, V. Li, G. M. Winter, W. J. Rogers, E. I. Martinez, and M. S. Denison Ah Receptor-Based Chemical Screening Bioassays: Application and Limitations for the Detection of Ah Receptor Agonists Toxicol. Sci., May 1, 2000; 55(1): 107 - 115. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. P. Ciolino and G. C. Yeh Inhibition of Aryl Hydrocarbon-Induced Cytochrome P-450 1A1 Enzyme Activity and CYP1A1 Expression by Resveratrol Mol. Pharmacol., October 1, 1999; 56(4): 760 - 767. [Abstract] [Full Text]
|
|
|
|
|
|
R. F. Casper, M. Quesne, I. M. Rogers, T. Shirota, A. Jolivet, E. Milgrom, and J.-F. Savouret Resveratrol Has Antagonist Activity on the Aryl Hydrocarbon Receptor: Implications for Prevention of Dioxin Toxicity Mol. Pharmacol., October 1, 1999; 56(4): 784 - 790. [Abstract] [Full Text]
|
|
|
|
 |
|
 J. J. Reiners Jr. and R. E. Clift Aryl Hydrocarbon Receptor Regulation of Ceramide-induced Apoptosis in Murine Hepatoma 1c1c7 Cells. A FUNCTION INDEPENDENT OF ARYL HYDROCARBON RECEPTOR NUCLEAR TRANSLOCATOR J. Biol. Chem., January 22, 1999; 274(4): 2502 - 2510. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M Phillips, E Enan, P. Liu, and F Matsumura Inhibition of 3T3-L1 adipose differentiation by 2,3,7,8-tetrachlorodibenzo-p-dioxin J. Cell Sci., January 1, 1995; 108(1): 395 - 402. [Abstract] [PDF]
|
|
 |
 |
 |
|
 |
 |
 |
